Anzeige
❌
Mehr »
Dienstag, 29.09.2026 - Börsentäglich über 12.000 News
Operation Vivaldi verändert die Kriegsführung: Bodendrohnen-Aktie mit Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
657 Leser
Artikel bewerten:
(2)

Calian Group Ltd.: Calian Announces the Appointment of New President of Calian Health

OTTAWA, ON / ACCESSWIRE / February 9, 2023 / Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, is proud to announce the appointment of Derek Clark as President, Health. He will take over the leadership of Calian Health from Gordon McDonald, who is retiring March 30, 2023, after a long and successful career in health and health services.

Mr. Clark is a seasoned health executive who has worked in a variety of companies from large multinationals, to start ups, and consulting practices. Beginning at GE Healthcare, he built his career aligning multiple business units and bringing the strength of GE's portfolio and expertise to positively impact key client relationships. Mr. Clark was later appointed the role of Chief Commercial Officer for GE Canada driving growth across all of the GE businesses. He then founded Resolve Consulting, a boutique consulting firm, where he was an executive commercialization consultant to an elite group of clients.

Most recently, Mr. Clark served as Chief Operating Officer for Neurolign Technologies, a medical device and pharma start-up focused on the diagnosis and treatment of concussions. Throughout his career, Mr. Clark has commercialized new health technologies, software, and services, successfully leading cross-business teams to win several large complex infrastructure projects through a unified deal strategy and rigorous execution.

"Derek Clark is a strong leader with a deep understanding of the multi-faceted health segment. He has a passion for teaching, mentoring and coaching leaders, a quality that we value highly here at Calian," says Kevin Ford, Calian CEO. "Derek's experience leading teams through the commercialization journey, change management and acquisitions will benefit the entire Calian Health team, and I am delighted to welcome him at such an exciting time in our growth. I would also like to thank Gordon McDonald for his years of service to Calian, leading the Calian Health team through the important transitions that have brought us to this point."

Mr. Clark will join Calian in early February 2023.

About Calian

www.calian.com

We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives-today and tomorrow. Every day, our employees live our values of customer commitment, integrity, innovation and teamwork to engineer reliable solutions that solve complex problems. That's Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American and International markets.

Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.

Media inquiries:

pr@calian.com
613-599-8600 x 2298

Investor Relations inquiries:
ir@calian.com

DISCLAIMER

Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as "intend", "anticipate", "believe", "estimate", "expect" or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company's most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
Tel: 613.599.8600 · Fax: 613-592-3664 · General info email: info@calian.com

SOURCE: Calian Group Ltd.

View source version on accesswire.com:
https://www.accesswire.com/738874/Calian-Announces-the-Appointment-of-New-President-of-Calian-Health

© 2023 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.